United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$42Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Torrey Pines Investment
WuXi AppTecWuXi PharmaTech (Cayman)Pharmstandard InternationalMissing a round, or an investor who was in one? Tell us.
Avelas Biosciences's investors include Avalon Ventures, Torrey Pines Investment, WuXi AppTec, WuXi PharmaTech (Cayman) and Pharmstandard International.
Avelas Biosciences has raised $42M across 4 rounds since 2012.
Avelas Biosciences's most recent round was a Series C of $20M in Aug 2016.
Its most recent round, $20M in Aug 2016, is also its largest on record.
Avelas Biosciences's first round on record, in Dec 2012, was backed by Avalon Ventures.
Avelas Biosciences's latest named round is a Series C, in Aug 2016.
Avelas Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
